Medable and Vault Health partner to expand direct-to-patient testing and eCare for decentralized clinical trials

PALO ALTO, Calif.–(BUSINESS WIRE)–Medable Inc. and Vault Health, Inc. today announced that the two fast-growing digital health leaders are partnering to integrate Vault’s expertise in diagnostics, logistics and remote care services with Vault’s end-to-end software platform. Medable for decentralized clinical trials. The partnership builds on a shared commitment to bring trials closer to patients through remote monitoring and highly tactile patient services, helping to make clinical trials more inclusive and accessible and ultimately, allows new therapies to be brought to market more quickly.

The two companies will combine Medable’s software-as-a-service (SaaS) platform with Vault’s technology operational capabilities to deliver a unified experience for patients, sites and clinical trial sponsors. Partnership will enable sponsors to seamlessly offer Vault home testing and diagnostics, home health care visits and televisits, virtual site capabilities and logistics, scheduling and condition tracking associates – all easily accessible through Medable’s dedicated applications for patients and sites.

Both companies have grown rapidly, quickly responding to pandemic needs for more flexible, remote options for expert care. Vault was the first to bring FDA-cleared home PCR tests to market and has now delivered over 10 million COVID tests to consumers, employers, public health agencies and school systems. Medable, likewise, has played a valuable role during the pandemic, enabling clinical research to continue remotely while supporting COVID vaccine research and therapeutics at record speed.

Medable has now deployed its SaaS platform through more than 150 decentralized and hybrid clinical trials in 60 countries, serving more than one million patients and research participants worldwide. By minimizing the need for in-person site visits, Medable customers have achieved unprecedented results, including 200% faster enrollment, 90% retention rates, and 50% cost reductions.

“The future of clinical research is decentralized – whether in a traditional clinic, a virtual site, a local pharmacy or someone’s home,” said Dr. Michelle Longmire, CEO and co-founder of Medable. “Our association with Vault Health allows us to make clinical trial participation much more convenient for patients, providing them with easy testing and diagnostic options, as well as expert remote care they can access from anywhere. anywhere.

Vault is a recognized leader in home testing and clinical logistics, where it deploys its nationwide medical practice of more than 1,000 clinicians to provide patient-centered diagnostics and care. Since launching in 2019, Vault has supported over five million telehealth visits and over 10 million patient interactions.

“As a digital health provider, we are focused on bringing care directly to people’s homes,” said Jason Feldman, CEO and co-founder of Vault. “The services we offer around home care, patient-centric logistics, testing and diagnostics, and virtual site capabilities are an ideal complement to Medable’s patient-centric clinical trial platform. Together, we can bridge the gap between clinical care and clinical research, paving the way for much simpler and faster decentralization of clinical trials.

About the vault

Vault accelerates better health outcomes through faster diagnosis, innovative clinical research, and digitally-driven care delivery. Vault provides care to patients on their terms, virtually or physically, leveraging its nationwide network of clinicians and data-driven technology platform to power its offerings. Vault has been a trusted leader in the fight against COVID-19, bringing to market the first FDA-cleared at-home PCR test. Since the start of the pandemic, Vault has provided more than 10 million COVID-19 tests to consumers, employers, public health agencies and school systems.

About Medable

medable is on a mission to deliver effective therapies to patients faster by transforming clinical drug development with disruptive technologies. The company’s digital platform streamlines data design, recruitment, retention and quality for decentralized trials, replacing siled systems with integrated digital tools, data and interfaces to accelerate trial execution. Medable connects patients, sites and clinical trial teams to improve patient access, experience and outcomes. Medable is a private, venture-backed company headquartered in Palo Alto, California.